Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
暂无分享,去创建一个
J. Emerson | R. Gibson | C. Halbert | A. Miller | B. Ramsey | S. Mcnamara | M. Aitken | A. D. Miller | Ronald L. Gibson | Moira L. Aitken | Moira L. Aitken | L. Ronald | Gibson